Table 2.

Blood chemistries and treatments characteristics

VariableESRD-CV n = 18ESRD-CV+ n = 17t-test, P
Hemoglobin (g/L)10.6 ± 1.4510.9 ± 1.500.46
HsCRP (mg/L)1.8 (1 to 7.5)5.2 (1 to 15)0.13
Serum albumin (g/L)35.3 ± 4.135.8 ± 2.40.38
Fibrinogen (g/L)4.02 ± 0.754.06 ± 0.950.46
Total cholesterol (mmol/L)4.51 ± 1.104.54 ± 1.350.61
LDL cholesterol (mmol/L)3.15 ± 1.053.16 ± 1.200.98
Serum calcium (mmol/L)2.24 ± 0.222.37 ± 0.170.06
Serum phosphates (mmol/L)1.71 ± 0.451.76 ± 0.420.39
Parathormone (pg/ml)476 ± 338535 ± 3930.42
25(OH)-vitamin D3 (μg/L)17.0 ± 6.710.3 ± 4.1<0.01
1,25(OH)2-vitamin D3 (pg/L)*18.9 ± 5.713.8 ± 4.8<0.01
Blood urea (mmol/L)29.1 ± 4.827.3 ± 4.30.09
Kt/V1.31 ± 0.201.28 ± 0.160.29
Homocysteine (μmol/L)34.3 ± 8.341.7 ± 14.40.19
Von Willebrand factor(%)157 ± 34213 ± 64<0.01
Plasminogen-activator inhibitor (μg/L)3.5 (2.5 to 10)7 (6–18)<0.05
Endothelin-1 (pg/ml)3.6 (2.6–8.2)1.9 (1.1 to 2.8)0.07
Erythropoietin (units/wk)3500 (2170 to 6160)5000 (3630 to 7370)0.84
ACE inhibitors (n patients)790.40
Beta blockers (n patients)650.48
Calcium channel blockers (n patients)470.29
Statins (n patients)28<0.05
Antiplatelet therapy (n patients)09<0.05
  • Values are means ± SD or Median (95% CI); n, number of patients.